دورية أكاديمية
Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer
| العنوان: | Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer |
|---|---|
| المؤلفون: | Bin Luo, Zujun Que, Xinyi Lu, Dan Qi, Zhi Qiao, Yun Yang, Fangfang Qian, Yi Jiang, Yan Li, Ronghu Ke, Xiaoyun Shen, Hua Xiao, Hegen Li, Erxi Wu, Jianhui Tian |
| المصدر: | Biological Procedures Online, Vol 25, Iss 1, Pp 1-17 (2023) |
| بيانات النشر: | BMC, 2023. |
| سنة النشر: | 2023 |
| المجموعة: | LCC:Medicine (General) LCC:Biology (General) |
| مصطلحات موضوعية: | Exosomes, Proteomics, Biomarkers, Non-small cell lung cancer (NSCLC), Metastasis, Medicine (General), R5-920, Biology (General), QH301-705.5 |
| الوصف: | Abstract Background Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related deaths worldwide, primarily due to its propensity for metastasis. Patients diagnosed with localized primary cancer have higher survival rates than those with metastasis. Thus, it is imperative to discover biomarkers for the early detection of NSCLC and the timely prediction of tumor metastasis to improve patient outcomes. Methods Here, we utilized an integrated approach to isolate and characterize plasma exosomes from NSCLC patients as well as healthy individuals. We then conducted proteomics analysis and parallel reaction monitoring to identify and validate the top-ranked proteins of plasma exosomes. Results Our study revealed that the proteome in exosomes from NSCLC patients with metastasis was distinctly different from that from healthy individuals. The former had larger diameters and lower concentrations of exosomes than the latter. Furthermore, among the 1220 identified exosomal proteins, we identified two distinct panels of biomarkers. The first panel of biomarkers (FGB, FGG, and VWF) showed potential for early NSCLC diagnosis and demonstrated a direct correlation with the survival duration of NSCLC patients. The second panel of biomarkers (CFHR5, C9, and MBL2) emerged as potential biomarkers for assessing NSCLC metastasis, of which CFHR5 alone was significantly associated with the overall survival of NSCLC patients. Conclusions These findings underscore the potential of plasma exosomal biomarkers for early NSCLC diagnosis and metastasis prediction. Notably, CFHR5 stands out as a promising prognostic indicator for NSCLC patients. The clinical utility of exosomal biomarkers offers the potential to enhance the management of NSCLC. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1480-9222 |
| العلاقة: | https://doaj.org/toc/1480-9222Test |
| DOI: | 10.1186/s12575-023-00223-0 |
| الوصول الحر: | https://doaj.org/article/0eff0551635e4a42b038e9e9465800ceTest |
| رقم الانضمام: | edsdoj.0eff0551635e4a42b038e9e9465800ce |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 14809222 |
|---|---|
| DOI: | 10.1186/s12575-023-00223-0 |